Issue navigation
Volume 120, Issue 3, February 2024
Cardiovascular Research Onlife
Clinical Commentaries
Enhancing cardiovascular risk prediction through proteomics?
Cardiovascular Research, Volume 120, Issue 3, February 2024, Pages e2–e4, https://doi.org/10.1093/cvr/cvae031
Editorials
Latent drivers for atrial fibrillation and specific patterns of localized fibrosis
Cardiovascular Research, Volume 120, Issue 3, February 2024, Pages 215–216, https://doi.org/10.1093/cvr/cvae032
The dual effects of miR-222 in cardiac hypertrophy: bridging pathological and physiological paradigms
Cardiovascular Research, Volume 120, Issue 3, February 2024, Pages 217–219, https://doi.org/10.1093/cvr/cvae033
SERCA2a microdomain cAMP changes in heart failure with preserved ejection fraction
Cardiovascular Research, Volume 120, Issue 3, February 2024, Pages 220–222, https://doi.org/10.1093/cvr/cvae030
Invited Review
Endothelial to mesenchymal transition: at the axis of cardiovascular health and disease
Cardiovascular Research, Volume 120, Issue 3, February 2024, Pages 223–236, https://doi.org/10.1093/cvr/cvae021
Review
Perilipin 1: a systematic review on its functions on lipid metabolism and atherosclerosis in mice and humans
Cardiovascular Research, Volume 120, Issue 3, February 2024, Pages 237–248, https://doi.org/10.1093/cvr/cvae005
Original Articles
Cardiac electrophysiology and arrhythmia
‘Trapped re-entry’ as source of acute focal atrial arrhythmias
Cardiovascular Research, Volume 120, Issue 3, February 2024, Pages 249–261, https://doi.org/10.1093/cvr/cvad179
Cardiac remodelling and heart failure
miR-222 inhibits pathological cardiac hypertrophy and heart failure
Cardiovascular Research, Volume 120, Issue 3, February 2024, Pages 262–272, https://doi.org/10.1093/cvr/cvad184
Remodelling of cAMP dynamics within the SERCA2a microdomain in heart failure with preserved ejection fraction caused by obesity and type 2 diabetes
Cardiovascular Research, Volume 120, Issue 3, February 2024, Pages 273–285, https://doi.org/10.1093/cvr/cvad178
Cardioprotection
Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicity
Cardiovascular Research, Volume 120, Issue 3, February 2024, Pages 286–300, https://doi.org/10.1093/cvr/cvae025
Hypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by sodium–glucose cotransporter 2 inhibitors
Cardiovascular Research, Volume 120, Issue 3, February 2024, Pages 301–317, https://doi.org/10.1093/cvr/cvae004
Immunity and inflammation
Marginal zone B cells produce ‘natural’ atheroprotective IgM antibodies in a T cell–dependent manner
Cardiovascular Research, Volume 120, Issue 3, February 2024, Pages 318–328, https://doi.org/10.1093/cvr/cvae027
